1. 37PPooling signaling and costimulatory domains in a flexible CARpool design. (17th December 2018) Authors: Springuel, L; Bolsée, J; Velghe, A; Agaugué, S; Gilham, D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Apabetalone, a BET inhibitor, attenuates inflammation induced by viral RNA mimetic and reduces SARS-CoV-2 spike protein binding regardless of variants. (3rd October 2022) Authors: Fu, L; Gilham, D; Stotz, S; Sarsons, C; Rakai, B; Tsujikawa, L; Wasiak, S; Johansson, J; Sweeney, M; Wong, N; Kulikowski, E Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bromodomain and extraterminal (BET) protein inhibitor, apabetalone, reduces ACE2 expression and attenuates SARS-CoV-2 infection in vitro. (14th October 2021) Authors: Gilham, D; Smith, A L; Fu, L; Moore, D Y; Muralidharan, A; Reid, S P M; Stotz, S C; Johansson, J O; Sweeney, M; Wong, N C W; El-Gamal, D; Kulikowski, E Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗